0.09Open0.09Pre Close0 Volume117 Open Interest7.00Strike Price0.00Turnover262.29%IV48.33%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.09Extrinsic Value100Contract SizeAmericanOptions Type0.1377Delta0.1504Gamma53.11Leverage Ratio-0.0313Theta0.0001Rho7.31Eff Leverage0.0012Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet